Millennium Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$358K Buy
+3,565
New +$366K ﹤0.01% 5229
2015
Q4
– Sell
-5,901
Closed -$291K – 3577
2015
Q3
$291K Sell
5,901
-2,055
-26% -$118K ﹤0.01% 2927
2015
Q2
$464K Sell
7,956
-3,195
-29% -$187K ﹤0.01% 2669
2015
Q1
$641K Buy
+11,151
New +$610K ﹤0.01% 2599

Other funds holding IHE

Millennium Management's IHE Position: Q3 2026 in Review

Millennium Management opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q3 2026: 3,565 shares worth $358K. The stake represents ﹤0.01% of the portfolio and ranks #5229 among its holdings. This is a return to the name: Millennium Management previously reported a position in IHE as recently as Q3 2015.

Millennium Management first reported a position in IHE in Q1 2015 and has held it in 4 quarters since. The position peaked at $641K in Q1 2015. 248 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

  • Millennium Management held 3,565 shares of iShares US Pharmaceuticals ETF worth $358K as of Q3 2026.
  • iShares US Pharmaceuticals ETF was a new Millennium Management position in Q3 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #5229 holding.
  • Millennium Management first reported a position in iShares US Pharmaceuticals ETF in Q1 2015 and has held it in 4 quarters since.
  • Millennium Management's iShares US Pharmaceuticals ETF position peaked at $641K in Q1 2015.
  • 248 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.